For PwC, ops and business strengths drive PRTM buy

Drug process and regulatory expert PRTM will be acquired by global consultancy PricewaterhouseCoopers. PRTM will join the PwC global advisory practice, among the world's largest consultancies. PwC cites operational strategy, execution and business model innovation among PRTM's strengths, which were no doubt attractive also to drugmaker Ranbaxy when it hired the consultancy to help extricate itself from regulatory hot water. Announcement

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.